This move is archived. Current quotes and coverage live on the stock page.
Get MBX alerts:
Microbix Biosystems Inc. faces a tough day on the TSX, with shares down 3.28%.
Microbix Biosystems Inc. (MBX.TO) has seen its stock price dip by 3.28% in the latest trading session, closing at CA$0.29. This decline raises concerns among investors about the company's current financial health and market position.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$40.41M
52W high
$0.33
52W low
$0.21
1W change
-1.67%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 35.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+35.6% Upside
Current Price
C$0.29
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
51.8%
Annualized
90-Day Vol
52.3%
Annualized
Trend (90d)
+37.2%
Annualized drift
90d Mean
C$0.34
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.31 | C$0.26 โ C$0.37 |
| 60 trading days | C$0.32 | C$0.25 โ C$0.41 |
| 90 trading days | C$0.34 | C$0.25 โ C$0.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With a market cap of CA$40.56 million and a negative profit margin, investors should remain cautious about Microbix's financial trajectory and the potential impact on future performance.
Microbix shares fall 3.28% today
With a market cap of CA$40.56 million and a profit margin of -38.62%, Microbix's financial struggles are evident.
Bull case
Despite the challenges, thereโs a glimmer of hope for investors. Microbix reported a 13% revenue growth in their Q1 2026 report compared to the previous quarter. This suggests that the company is showing some operational resilience, which could be a positive sign moving forward.
Bear case
On the flip side, the ongoing net losses and absence of dividends highlight serious financial challenges. These factors could make potential investors think twice before getting involved with Microbix.
Market Performance Overview
Advertisement
In the latest trading session, Microbix Biosystems Inc. saw its stock price decrease by 3.28%, closing at CA$0.29. This decline comes amidst a broader market context where investors are increasingly cautious about companies with negative profit margins and ongoing losses.
Financial Health Concerns
With a market cap of CA$40.56 million and a troubling profit margin of -38.62%, Microbix's financial health is under scrutiny. Investors are advised to consider these metrics when evaluating the stock's potential for recovery.
Looking Ahead
As Microbix prepares to release its Q2 fiscal 2026 results, stakeholders will be keen to see if the company can turn around its financial performance and provide a more optimistic outlook for the future. For more insights, check the latest updates on Microbix Biosystems Inc..
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
